{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:48:22Z","timestamp":1762674502691,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.canrad.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T04:06:15Z","timestamp":1624507575000},"page":"445-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiation dose to the low axilla in patients treated for early-stage breast cancer by locoregional intensity-modulated radiotherapy (IMRT)"],"prefix":"10.1016","volume":"26","author":[{"given":"L.M.","family":"Abbassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ars\u00e8ne-Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.06.002_bib0125","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.06.002_bib0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.06.002_bib0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2021.06.002_bib0150","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2021.06.002_bib0155","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.06.002_bib0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.06.002_bib0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2017.07.002","article-title":"Evolution of radiation techniques in the treatment of breast cancer (BC) patients: from 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT)","volume":"124","author":"Arsene-Henry","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0180","doi-asserted-by":"crossref","first-page":"23608","DOI":"10.18632\/oncotarget.25286","article-title":"The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy\u2014a single center experience","volume":"9","author":"Arsene-Henry","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2021.06.002_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0190","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"D\u00e9lin\u00e9ation des organes \u00e0 risque et contraintes dosim\u00e9triques","volume":"20","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.06.002_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9610(02)01013-9","article-title":"Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer","volume":"184","author":"Chung","year":"2002","journal-title":"Am J Surg"},{"key":"10.1016\/j.canrad.2021.06.002_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1259\/bjr\/29242407","article-title":"Irradiation with standard tangential breast fields in patients treated with conservative surgery and sentinel node biopsy: using a three-dimensional tool to evaluate the first level coverage of the axillary nodes","volume":"78","author":"Orecchia","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0210","doi-asserted-by":"crossref","DOI":"10.1002\/jso.10148","article-title":"Are the axillary lymph nodes treated by standard tangent breast fields?","volume":"81","author":"McCormick","year":"2002","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0360-3016(01)01595-4","article-title":"Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: results of a prospective study","volume":"51","author":"Aristei","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.002_bib0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0360-3016(01)01684-4","article-title":"Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation","volume":"51","author":"Schlembach","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.002_bib0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.radonc.2007.01.003","article-title":"Dose received by the sentinel node volume during tangential radiation therapy to the breast","volume":"82","author":"Zunino","year":"2007","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0230","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1245\/s10434-014-3966-1","article-title":"Breast Radiotherapy (RT) Using Tangential Fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement","volume":"21","author":"Belkacemi","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2021.06.002_bib0235","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/1097-0142(19901215)66:12<2498::AID-CNCR2820661209>3.0.CO;2-X","article-title":"A standard dose of radiation for \u201cmicroscopic disease\u201d is not appropriate","volume":"66","author":"Marks","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.06.002_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","article-title":"Timing of lymphedema after treatment for breast cancer: when are patients most at risk?","volume":"103","author":"McDuff","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:15Z","timestamp":1761136455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1278321821000986"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation dose to the low axilla in patients treated for early-stage breast cancer by locoregional intensity-modulated radiotherapy (IMRT)","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}